Animal trial of Covaxin gets robust immune responses, says Bharat Biotech | News – Times of India Videos


Sep 12, 2020, 08:57PM ISTSource: TOI.in

Bharat Biotech International Limited has announced that its Covid-19 vaccine candidate, Covaxin, has shown positive efficacy in animal studies and generated robust immune responses. Covaxin, developed by the Indian Council of Medical Research and Bharat Biotech, is being tested at 12 institutes across India. This indigenous vaccine is one of the front runners in the race for a coronavirus vaccine in the country. The Hyderabad-based firm said, ‘Bharat Biotech proudly announces the animal study results of Covaxin- these results demonstrate the protective efficacy in a live viral challenge model. The vaccine candidate was found to generate robust immune responses. Thus, preventing infection and disease in the primates upon high amounts of exposure to live SARS-CoV-2 virus.’

.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.